Learn
Peptide-by-peptide guides.
Plain-language education on individual research peptides. Each guide covers mechanism, common research protocols, side-effect profile, and the primary literature.
Plain-language education on individual research peptides. Each guide covers mechanism, common research protocols, side-effect profile, and the primary literature.
Pentadecapeptide studied for angiogenesis and tendon-to-bone repair. The most-cited peptide in recovery research.
Synthetic fragment of thymosin beta-4. Studied for cell migration and tissue regeneration. Frequently stacked with BPC-157.
Lys-Pro-Val tripeptide derived from α-MSH. Studied for inflammatory pathways in IBD and skin models.
Triple agonist (GLP-1 / GIP / glucagon). Phase 2 trial: 24.2% mean weight reduction at 12 mg over 48 weeks.
Dual GLP-1 / GIP agonist. SURMOUNT-1 trial: 20.9% mean weight reduction at 15 mg.
GLP-1 receptor agonist. Phase 3 STEP-1: 15-17% mean weight loss over 68 weeks.
Long-acting amylin analog. Studied paired with GLP-1 for enhanced weight-loss effect (CagriSema).
Selective ghrelin receptor agonist. Clean side-effect profile — minimal cortisol or prolactin elevation.
Bioidentical fragment of endogenous GHRH (residues 1-29). Long track record, short half-life.
Long-acting GHRH analog. FDA-approved (as Egrifta) for HIV-associated lipodystrophy.
Ala-Glu-Asp-Gly tetrapeptide from the pineal gland. Studied for telomerase activity in cellular aging models.
Central coenzyme in sirtuin activation and DNA repair pathway signaling.
16-amino-acid peptide encoded within mitochondrial DNA. Studied for insulin sensitivity and metabolic homeostasis.
Synthetic analog of ACTH fragment 4-10. Studied for cognitive endurance and BDNF expression.
Delta sleep-inducing peptide. Studied for sleep architecture and cortisol regulation.
Endogenous nonapeptide. Studied for cortisol regulation and stress-response research.